glp-1 different types Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The GLP-1 Agonists and Obesity:

For hepatic specification, the study identified a novel small-molecule cocktail, VDF (Vitamin C, Dihexa, and Forskolin), that could effectively substitute for expensive growth factors like BMPs, FGFs, and HGF

Tirzepatide (Zepbound) 15 mg, 72 weeks Semaglutide (Wegovy) 2.4 mg, 68 weeks Oral semaglutide (pill) 25 mg, 64 weeks Individual results vary

Given the high prevalence of NAFLD among people with type 2 diabetes (estimated at 5570%), many patients receiving GLP-1 therapy for diabetes will have concurrent liver disease

Patient-reported outcomes also reflected positive changes

Semaglutide with B12 is given as a subcutaneous injection, usually once a week